NK

NantKwest Stock Price

28.38
1.58 (5.9%)
Upgrade to Real-Time
Afterhours (Closed)
28.38
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
NantKwest Inc NK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.58 5.9% 28.38 19:58:56
Open Price Low Price High Price Close Price Prev Close
27.95 26.50 30.32 28.28 26.80
Bid Price Ask Price Spread News
28.30 29.60 1.30 - 3
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,838 1,296,952 $ 28.97 $ 37,574,048 3,494,200 2.52 - 45.42
Last Trade Time Type Quantity Stock Price Currency
19:58:17 formt 500 $ 28.38 USD

NantKwest Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.09B 108.73M 38.71M $ 43.00k $ - -0.71 -23.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

NantKwest News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.2334.61723.1527.671,320,959-4.85-14.6%
1 Month24.0045.4223.1533.021,689,3064.3818.25%
3 Months12.3745.4210.2120.172,504,75016.01129.43%
6 Months6.2245.426.0916.301,712,49822.16356.27%
1 Year4.4145.422.5212.181,734,11923.97543.54%
3 Years4.6545.420.939.05944,34423.73510.32%
5 Years9.6145.420.938.49692,40018.77195.32%

NantKwest Description

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.


Your Recent History
NASDAQ
NK
NantKwest
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.